It was revealed that sulindac sulfide can inhibit tumor cell invasion in vitro at concentrations less than those required to inhibit tumor cells growth, by suppressing NF-κB-mediated transcription of microRNAs [81]. This evidence concerns the gene NFKB1 and neoplasm.